Live Breaking News & Updates on Preclinical Model Of Disease

Stay updated with breaking news from Preclinical model of disease . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. Sinha on the Antitumor Effects of Onvansertib in a Preclinical Endometroid Endometrial Cancer Model

Nikita Sinha, MD, discusses the potential effects of onvansertib on endometroid endometrial cancer pathogenesis in a preclinical model. ....

Nikita Sinha , Division Of Gynecologic Oncology , University Of North Carolina , Department Of Obstetrics Gynecology , Chapel Hill School Of Medicine , Society Of Gynecologic Oncology Winter Meeting , Gynecologic Oncology , North Carolina , Hill School , Gynecologic Oncology Winter Meeting , Go Winter Meeting , Onclive Tv , Endometroid Endometrial Cancer , Oral Plk1 Inhibitor , Onvansertib , Preclinical Model Of Disease ,